AAAAAA

   
Results: 1-13 |
Results: 13
Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders
Authors: Sauleda, S Juarez, A Esteban, JI Altisent, C Ruiz, I Puig, L Esteban, R Guardia, J
Citation: S. Sauleda et al., Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders, HEPATOLOGY, 34(5), 2001, pp. 1035-1040
Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays
Authors: Castro, FJ Sauleda, S Esteban, JI Viladomiu, L Martell, M Dragon, E Esteban, R Guardia, J
Citation: Fj. Castro et al., Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays, J VIROL MET, 91(1), 2001, pp. 51-58
Activated extracellular signal-regulated kinases: Association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments
Authors: Albanell, J Codony-Servat, J Rojo, F Del Campo, JM Sauleda, S Anido, J Raspall, G Giralt, J Rosello, J Nicholson, RI Mendelsohn, J Baselga, J
Citation: J. Albanell et al., Activated extracellular signal-regulated kinases: Association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments, CANCER RES, 61(17), 2001, pp. 6500-6510
Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy
Authors: Pradat, P Chossegros, P Bailly, F Pontisso, P Saracco, G Sauleda, S Thursz, M Tillmann, H Vlassopoulou, H Alberti, A Braconier, JH Esteban, JI Hadziyannis, S Manns, M Rizzetto, M Thomas, HC Trepo, C
Citation: P. Pradat et al., Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy, J VIRAL HEP, 7(3), 2000, pp. 203-210
Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: Characterization in relation to antiphospholipid syndrome
Authors: Ordi-Ros, J Villarreal, J Monegal, F Sauleda, S Esteban, I Vilardell, M
Citation: J. Ordi-ros et al., Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: Characterization in relation to antiphospholipid syndrome, CL DIAG LAB, 7(2), 2000, pp. 241-244
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature
Authors: Touzet, S Kraemer, L Colin, C Pradat, P Lanoir, D Bailly, F Coppola, RC Sauleda, S Thursz, MR Tillmann, H Alberti, A Braconier, JH Esteban, JI Hadziyannis, SJ Manns, MP Saracco, G Thomas, HC Trepo, C
Citation: S. Touzet et al., Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature, EUR J GASTR, 12(6), 2000, pp. 667-678
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C
Authors: Sauleda, S Esteban, JI Altisent, C Puig, L Esteban, R Guardia, J
Citation: S. Sauleda et al., Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C, THROMB HAEM, 83(6), 2000, pp. 807-810
Prevalence of hepatitis g virus in healthy children in liver disease, and human immunodeficiency virus-1 infection: Response to interferon
Authors: Infante, D Pich, M Tormo, R Sauleda, S Montane, C Esteban, JI Esteban, R
Citation: D. Infante et al., Prevalence of hepatitis g virus in healthy children in liver disease, and human immunodeficiency virus-1 infection: Response to interferon, J PED GASTR, 30(4), 2000, pp. 385-390
Utility of early testing for HCV viremia as predictive factor of sustainedresponse during interferon or interferon plus ribavirin treatment
Authors: Castro, FJ Esteban, JI Sauleda, S Viladomiu, L Dragon, EA Esteban, R Guardia, J
Citation: Fj. Castro et al., Utility of early testing for HCV viremia as predictive factor of sustainedresponse during interferon or interferon plus ribavirin treatment, J HEPATOL, 32(5), 2000, pp. 843-849
Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver
Authors: Cabot, B Martell, M Esteban, JI Sauleda, S Otero, T Esteban, R Guardia, J Gomez, J
Citation: B. Cabot et al., Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver, J VIROLOGY, 74(2), 2000, pp. 805-811
Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus
Authors: Sauleda, S Reesink, HJ Esteban, JI Hess, G Esteban, R Guardia, J
Citation: S. Sauleda et al., Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus, J MED VIROL, 59(1), 1999, pp. 45-51
High-throughput real-time reverse transcription PCR quantitation of hepatitis C virus RNA
Authors: Martell, M Gomez, J Esteban, JI Sauleda, S Quer, J Cabot, B Esteban, R Guardia, J
Citation: M. Martell et al., High-throughput real-time reverse transcription PCR quantitation of hepatitis C virus RNA, J CLIN MICR, 37(2), 1999, pp. 327-332
Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus-infected blood
Authors: Sauleda, S Esteban, JI Hernandez, JM Reesink, H Castella, D Quer, J Hess, G Esteban, R Guardia, J
Citation: S. Sauleda et al., Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus-infected blood, TRANSFUSION, 39(6), 1999, pp. 633-638
Risultati: 1-13 |